Detalhe da pesquisa
1.
Understanding eHealth Cognitive Behavioral Therapy Targeting Substance Use: Realist Review.
J Med Internet Res
; 23(1): e20557, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475520
2.
Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials.
Am J Drug Alcohol Abuse
; 47(3): 280-304, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33780647
3.
Non-beverage alcohol consumption among individuals experiencing chronic homelessness in Edmonton, Canada: a cross-sectional study.
Harm Reduct J
; 18(1): 108, 2021 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657618
4.
A Case Report: Rapid Micro-Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended-Release in an Adolescent With Severe Opioid Use Disorder.
Am J Addict
; 29(6): 531-535, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32346944
5.
Canada's Response to the Dual Public Health Crises: A Cautionary Tale.
Can J Psychiatry
; 66(4): 349-353, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567889
6.
Been There, Done That: Lessons from Vancouver's Efforts to Stem the Tide of Overdose Deaths.
Can J Psychiatry
; 65(6): 377-380, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32174152
7.
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.
J Addict Med
; 18(1): 82-85, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847573
8.
Systematic review on intentional non-medical fentanyl use among people who use drugs.
Front Psychiatry
; 15: 1347678, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38414500
9.
Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: "Ultrarapid Micro-Dosing" Proof of Concept.
J Psychoactive Drugs
; 55(1): 94-101, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35152847
10.
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method.
J Addict Med
; 17(2): 233-236, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36149002
11.
Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial.
Addiction
; 118(2): 284-294, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971297
12.
Cost Analysis of Buprenorphine Extended-Release Injection Versus Sublingual Buprenorphine/Naloxone Tablets in a Correctional Setting.
J Correct Health Care
; 28(6): 368-371, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342953
13.
Case report: acute care management of severe opioid withdrawal with IV fentanyl.
Addict Sci Clin Pract
; 17(1): 22, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382882
14.
Treatment approaches and outcome trajectories for youth with high-risk opioid use: A narrative review.
Early Interv Psychiatry
; 16(3): 207-220, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913589
15.
Shifting North American drug markets and challenges for the system of care.
Int J Ment Health Syst
; 15(1): 86, 2021 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34930389
16.
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial.
Addict Sci Clin Pract
; 16(1): 11, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579359